ClinicalTrials.govpublic full text
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years
hematologic diseases, anaemia, sickle cell, sickle cell disease, first time in human study, 218471, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 806369
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.